New research by School of Nursing professor Sheila Ridner finds that a special scan measuring lymphatic fluid volume is significantly better than a tape measure at predicting which women undergoing treatment for breast cancer are at risk of developing a common complication resulting from damaged lymph nodes.
Until now, researchers have assumed that the growth of solid tumors originates from cancer stem cells characterized by specific surface markers, which develop in a fixed, hierarchical order. In a joint interdisciplinary project led by the Luxembourg Institute of Health (LIH), researchers now show that cancer cells of glioblastomas -- conspicuously aggressive solid brain tumors -- manifest developmental plasticity and their phenotypic characteristics are less constrained than believed.
The study shows that tumour suppressor hnRNP K can lead to cancer. Overexpression of the gene may lead to B-cell lymphoma, the most common type of blood cancer. Lymphoma patients might benefit from more personalised treatments.
A new study indicates that PSA, a prostate cancer marker, is one of the catalysts that activate vascular endothelial and lymphangiogenic growth factors which contribute to the spread of cancer.
A new study has shown that more than half of physicians -- primary care doctors and specialists -- may be unaware that dense breasts are associated with an increased risk of breast cancer, and nearly half reported not being aware of laws requiring physicians to inform women about mammography-related breast density risks and supplemental screening options.
Researchers from the Hubrecht Institute developed a human model in which they use organoids, or mini organs, to study the function of specific genes that are mutated in liver cancer. Using this method, they have found that mutations in BAP1, a gene commonly mutated in liver cancer, changes the behavior of the cells, which may make them more likely to be invasive. Their results were published in Cell Stem Cell.
A decade-old treatment recommendation for people with cancer to take a 'slowly slowly' approach to exercise has been replaced with new guidelines recommending a personalized exercise program including high-intensity workouts to achieve the best treatment outcome.
At ASCO 2019, SWOG investigators will report on 16 group-led trials, one jointly-led study, and another 12 involving partners. Presentation topics illustrate SWOG's wide-ranging portfolio, with talks and posters on treatment or prevention of bladder, breast, colorectal, lung, pancreatic, prostate, and rare cancers, as well as melanoma and multiple myeloma. SWOG investigators will make a particularly strong showing in symptom control, survivorship, and quality of care trials.
York University scientists have uncovered a unique set of genes that play a role in muscle cellular gene expression and differentiation which could lead to new therapeutic targets to prevent the spread of muscle cancer.
A specialized pain management program for patients who underwent robotic surgery for urologic cancers resulted in just 8% going home with narcotics after discharge, compared to 100% who would have received them without this enhanced recovery protocol.